Wells Fargo
ALXN

Wells Fargo’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-904,290
Closed -$166M 7558
2021
Q2
$166M Buy
904,290
+338,049
+60% +$62.1M 0.04% 442
2021
Q1
$86.6M Sell
566,241
-307,223
-35% -$47M 0.02% 728
2020
Q4
$136M Sell
873,464
-51,200
-6% -$8M 0.03% 506
2020
Q3
$106M Sell
924,664
-75,114
-8% -$8.6M 0.03% 539
2020
Q2
$112M Sell
999,778
-339,191
-25% -$38.1M 0.03% 497
2020
Q1
$120M Sell
1,338,969
-316,222
-19% -$28.4M 0.04% 404
2019
Q4
$179M Sell
1,655,191
-273,588
-14% -$29.6M 0.05% 382
2019
Q3
$189M Sell
1,928,779
-526,693
-21% -$51.6M 0.05% 360
2019
Q2
$322M Buy
2,455,472
+366,523
+18% +$48M 0.09% 212
2019
Q1
$282M Buy
2,088,949
+319,172
+18% +$43.1M 0.08% 228
2018
Q4
$172M Sell
1,769,777
-22,543
-1% -$2.19M 0.06% 321
2018
Q3
$249M Buy
1,792,320
+306,585
+21% +$42.6M 0.07% 282
2018
Q2
$184M Buy
1,485,735
+178,018
+14% +$22.1M 0.05% 348
2018
Q1
$146M Buy
1,307,717
+65,994
+5% +$7.36M 0.04% 434
2017
Q4
$148M Sell
1,241,723
-316,808
-20% -$37.9M 0.04% 428
2017
Q3
$219M Buy
1,558,531
+383,713
+33% +$53.8M 0.07% 303
2017
Q2
$143M Sell
1,174,818
-21,897
-2% -$2.66M 0.05% 409
2017
Q1
$145M Sell
1,196,715
-685,315
-36% -$83.1M 0.05% 404
2016
Q4
$230M Sell
1,882,030
-1,543,010
-45% -$189M 0.08% 251
2016
Q3
$420M Sell
3,425,040
-221,639
-6% -$27.2M 0.15% 145
2016
Q2
$426M Sell
3,646,679
-975,673
-21% -$114M 0.17% 141
2016
Q1
$644M Sell
4,622,352
-1,353,659
-23% -$188M 0.26% 85
2015
Q4
$1.14B Sell
5,976,011
-259,806
-4% -$49.6M 0.45% 31
2015
Q3
$975M Buy
6,235,817
+838,201
+16% +$131M 0.41% 36
2015
Q2
$976M Buy
5,397,616
+1,113,561
+26% +$201M 0.38% 38
2015
Q1
$742M Sell
4,284,055
-112,316
-3% -$19.5M 0.29% 69
2014
Q4
$813M Sell
4,396,371
-105,646
-2% -$19.5M 0.32% 59
2014
Q3
$747M Sell
4,502,017
-731,184
-14% -$121M 0.31% 57
2014
Q2
$818M Sell
5,233,201
-797,511
-13% -$125M 0.34% 46
2014
Q1
$917M Sell
6,030,712
-1,669,284
-22% -$254M 0.39% 37
2013
Q4
$1.02B Buy
7,699,996
+1,741,276
+29% +$231M 0.44% 32
2013
Q3
$692M Buy
5,958,720
+17,528
+0.3% +$2.04M 0.33% 55
2013
Q2
$548M Buy
+5,941,192
New +$548M 0.28% 75